Paul Tudor Jones Harmony Biosciences Holdings, Inc. Transaction History

Tudor Investment Corp Et Al

  • $26.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$19.2 - $33.78 $619,641 - $1.09 Million
32,273 New
32,273 $1.04 Million
Q2 2023

Aug 14, 2023
BUY
$30.5 - $37.4 $11,315 - $13,875
371 Added 1.25%
30,142 $1.06 Million
Q1 2023

May 15, 2023
BUY
$30.8 - $53.92 $916,946 - $1.61 Million
29,771 New
29,771 $972,000
Q4 2020

Feb 16, 2021
SELL
$31.74 - $51.34 $197,930 - $320,156
-6,236 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$30.96 - $44.39 $193,066 - $276,816
6,236 New
6,236 $211,000

Others Institutions Holding HRMY

# of Institutions
242
Shares Held
45.2M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email